"the hotter it is, the more water he needs to cool down his body temperature," corinna, 40, who lives in germany, wrote
.
u.s.
.
.
.
eptinezumab is in phase iii trials. its maker plans to submit an application with the fda later this year. it is for chronic migraine prevention.
.
. here are 4 mass. biotechs making noise at the ash conference so far
.